Resource Library

Decentralized technologies are transforming clinical trials by addressing patient recruitment and engagement challenges.

Redefine your clinical trials: Join us on October 25th for a live product spotlight on Castor’s eConsent solution.

eConsent plays a pivotal role in optimizing modern clinical trials, but the nuance around its adoption for pharmaceutical and medical device companies remains a consideration for implementation teams.

Our on demand webinar with Leanne Walsh from Northern Light Lifescience to dive into the process of eConsent adoption from sponsor to site.

Download our White Paper: Preparing for Post-Market Clinical Follow-up (PMCF) under EU MDR (European Union Medical Device Regulation) now.

Decentralized technologies are transforming clinical trials by addressing patient recruitment and engagement challenges.

His exceptional leadership experience and extensive industry knowledge in the healthcare and technology industries will be invaluable to Castor

In this blog we cover how eConsent benefits trials and aligns with IRB ethical commitments, how to prepare your IRB submission for approval, and the future impact of large language models on the informed consent process.

Essity needed to recruit participants for a decentralized clinical trial. Deploying virtual methods with the help of Castor, the team was able to successfully create a trial ecosystem that was accessible to all participants. Castor allowed Essity to streamline its clinical operations while also making it easier for participants to navigate the journey from start to finish.

Castor, an industry leader in modular, patient-centric, clinical trial technology, today announced the appointment of Jeanne Hecht to its Board of Directors